Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Population Health Research Institute | OTHER |
Not provided
Not provided
Not provided
Not provided
Oxygen therapy is administered to all patients during general anesthesia to maintain tissue oxygenation and prevent hypoxia and ischemia. However, liberal use of oxygen may lead to hyperoxia and some studies suggest that supranormal levels of arterial oxygen saturation may lead to complications. In this post hoc substudy of the VISION cohort, we plan to assess the association between perioperative inspired oxygen fraction (FiO2) and myocardial injury after non-cardiac surgery (MINS).
Patients will be divided into five groups of median intraoperative FiO2 (quintiles), in which baseline characteristics and outcomes will be illustrated.
The odds ratio (OR) for the primary and secondary outcomes will be calculated in a logistic regression analysis with median FiO2 (continuous variable) as independent variable.
Analyses are performed with multiple logistic regression with adjustment for the following potentially confounding variables:
Age ≥75 years. Male sex. Current atrial fibrillation. History of diabetes. History of congestive heart failure. History of coronary artery disease. History of recent (i.e., < 6 months) high-risk coronary artery disease. History of stroke. History of peripheral vascular disease. History of hypertension. Preoperative eGFR (<30 vs. 30-44 vs. 45-59 vs. ≥60 mL/min/1.73m2). Low-risk surgery. Duration of surgery.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Inspiratory oxygen fraction | Drug | Median inspiratory oxygen fraction during general anesthesia |
| Measure | Description | Time Frame |
|---|---|---|
| Myocardial injury after non-cardiac surgery (MINS) | Number of participants with MINS in the specified oxygen groups. MINS is defined as either ischemic troponin elevation or myocardial infarction after non-cardiac surgery. | Within 30 days after surgery. |
| Measure | Description | Time Frame |
|---|---|---|
| All-cause mortality | Number of deaths within 30 days after surgery | Within 30 days after surgery |
| Myocardial infarction | Number of participants with myocardial infarction within 30 days after surgery |
| Measure | Description | Time Frame |
|---|---|---|
| Vascular mortality | Number of vascular deaths within 30 days after surgery | Within 30 days after surgery |
| Non-fatal cardiac arrest | Number of participants with non-fatal cardiac arrest within 30 days after surgery |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
All patients entered in the VISION database, undergoing noncardiac surgery in general anesthesia.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Christian S. Meyhoff, MD, PhD | University hospital Bispebjerg Frederiksberg | Principal Investigator |
| PJ Devereaux, MD, PhD | Population Healt Research Institute | Study Chair |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Cleveland Clinic | Cleveland | Ohio | 44195 | United States | ||
| Walter C. Mackenzie Health Sciences Centre |
Not provided
| ID | Term |
|---|---|
| D018496 | Hyperoxia |
| D009203 | Myocardial Infarction |
| ID | Term |
|---|---|
| D012818 | Signs and Symptoms, Respiratory |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D017202 | Myocardial Ischemia |
Not provided
Not provided
Not provided
Not provided
Not provided
| Within 30 days after surgery |
| MINS | Number of participants with MINS not fulfilling the fourth universal definition of myocardial infarction | Within 30 days after surgery |
| Rehospitalization for vascular reasons | Number of participants rehospitalized for vascular reasons within 30 days after surgery | Within 30 days after surgery |
| Pneumonia | Number of participants with pneumonia within 30 days after surgery | Within 30 days after surgery |
| Within 30 days after surgery |
| Cardiac revascularization procedure | Number of participants undergoing cardiac revascularization procedure within 30 days after surgery | Within 30 days after surgery |
| Pulmonary embolism | Number of participants with pulmonary embolism within 30 days after surgery | Within 30 days after surgery |
| New-onset clinically important atrial fibrillation | Number of participants with new-onset clinically important atrial fibrillation within 30 days after surgery | Within 30 days after surgery |
| Peripheral arterial thrombosis | Number of participants with peripheral arterial thrombosis within 30 days after surgery | Within 30 days after surgery |
| Severe sepsis or septic shock | Number of participants with severe sepsis or septic shock within 30 days after surgery | Within 30 days after surgery |
| Surgical wound infection | Number of participants with surgical wound infection defined as surgical incision infection or surgical abscess | Within 30 days after surgery |
| Deep venous thrombosis | Number of participants with deep venous thrombosis within 30 days after surgery | Within 30 days after surgery |
| Edmonton |
| Canada |
| Prince of Wales Hospital | Hong Kong | China |
| Foundation CardioInfanil | Bogotá | Colombia |
| Bispebjerg Hospital | Copenhagen | NV | 2400 | Denmark |
| Christian Medical College | Ludhiāna | India |
| University Malaya Medical Centre | Kuala Lumpur | Malaysia |
| Inkosi Albert Luthuli Hospital | Durban | South Africa |
| D006331 | Heart Diseases |
| D002318 | Cardiovascular Diseases |
| D014652 | Vascular Diseases |
| D007238 | Infarction |
| D007511 | Ischemia |
| D010335 | Pathologic Processes |
| D009336 | Necrosis |